News & Updates

Show Multimedia Only
Novel RSV vaccine safe to use in solid organ transplant recipients
Novel RSV vaccine safe to use in solid organ transplant recipients
17 Nov 2025 byStephen Padilla

Two doses of mRNA-1345 respiratory syncytial virus (RSV) vaccine 50 µg administered 56 days apart do not yield any safety concerns and are well-tolerated among solid organ transplant recipients (SOTRs), according to a study presented at IDWeek 2025.

Novel RSV vaccine safe to use in solid organ transplant recipients
17 Nov 2025